Clinical Microbiology Market Value Anticipated To Reach US$ 6.5 Bn By 2027: Impact of COVID-19 on the Market

NEXT STORY
Orgenesis Third Quarter 2020 Revenue Increases 40% Reflecting Continued Progress of POCare Platform
PREV STORY
Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial of LSALT peptide to Treat Complications from Covid-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of ATRC-101 in Patients with Select Solid Tumors

author_avatar
NASDAQ Market News

Basilea announces completion of its transaction involving a partial repurchase of its existing bond and the issuance of a new bond

author_avatar
NASDAQ Market News

Paratek Pharmaceuticals Announces Initiation of Phase 2b Study in Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by Mycobacterium abscessus Complex (MABc) with NUZYRA® (omadacycline)

author_avatar
NASDAQ Market News